Back to Results
First PageMeta Content



Updated immunologic and clinical results from a phase 2 study of AGS-003, an autologous dendritic cell based therapy, in patients with newly diagnosed metastatic renal cell carcinoma in combination with sunitinib. R. A.
Add to Reading List

Document Date: 2013-12-05 12:55:52


Open Document

File Size: 662,23 KB

Share Result on Facebook